Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing.
Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology.
Molecular diagnostics are highly effective in diagnosing infectious diseases and performing preventive cancer screening thus helping healthcare professionals to prescribe accurate therapeutic interventions in the early stages of diseases. Increasing prevalence of hospital acquired infections and other communicable infections are anticipated to drive the sector expansion over the forecast period.
The classification of molecular microbiology includes quantitative PCR detection diagnostic kits, pathogenic microorganisms\' diagnostic kits and other. The proportion of pathogenic microorganisms\' diagnostic kits in 2016 is about 45.8%. PCR was the largest segment in terms of revenue generation, Moreover, the growing availability of diseases-specific; real time PCR kits are further estimated to boost the growth.
Molecular Microbiology is application for human and veterinary. The most of Molecular Microbiology is used for human, and the market share in 2016 is about 92.5%.
The report offers detailed coverage of Molecular Microbiology industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Molecular Microbiology by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Molecular Microbiology market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Molecular Microbiology market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
At the same time, we classify Molecular Microbiology according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Quantitative PCR Detection Diagnostic Kits
Pathogenic Microorganisms Diagnostic Kits
Market by Application
Human
Veterinary
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Molecular Microbiology market for the forecast period 2021 - 2025?
• What are the driving forces in the Molecular Microbiology market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Molecular Microbiology industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?